Stock detail
Janux Therapeutics (JANX) stock price, chart, and key data
View Janux Therapeutics stock price, chart movement, and headline metrics on Woodstock's stock detail page.
Stock detail
Janux Therapeutics
JANX · XNAS
$17.19
-2.77%
-$0.49
Key metrics
52-week range
$4.75 - $1.00
Close price
$17.68
Market cap
$1.1B
P/E ratio
-50.51
Beta
0.62
About the company
Janux Therapeutics Inc
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. The proprietary technology of the company has enabled the development of distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr), Tumor Activated Immunomodulators (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms. The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.
Analyst rating summary
A current read on analyst sentiment from the insight feed.
Mean target
$34.22
10
Buy
/ 11
Recent calls
08/24/2026
Wolfe Research
Kalpit Patel
Buy · Price target $23.00
08/13/2026
William Blair
Matt Phipps
Buy
08/11/2026
Stifel Nicolaus
Stephen Willey
Buy · Price target $35.00
Ticker holders
Review politician disclosures and insider transactions in tabs.
No holder data is available for this category yet.
24/5 Trading
Act on the stock when the timing works for you.
With Woodstock, you can move from chart review to order placement in one flow. Trade eligible US stocks 24/5, even outside regular market hours.
*24-hour trading is available except during system maintenance. Some stocks are not eligible for extended-hours trading.
Download the app